Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer
M. E. Gedik, O. Saatci, N. Oberholtzer, M. Uner, O. Akbulut, M. Cetin, M. Aras, K. Ibis, B. Caliskan, E. Banoglu, S. Wiemann, A. Uner, S. Aksoy, S. Mehrotra, O. Sahin
This study shows that T-DM1 induces immunogenic cell death (ICD) in HER2-positive breast cancer, which is lost in resistance, and that targeting TACC3 restores ICD and enhances T-DM1 response.
bioRxiv · Sep 12, 2023 · PreprintCancer Biology